24/7 Market News Snapshot 02 September, 2025 – Strata Skin Sciences, Inc. Common Stock (NASDAQ:SSKN)

September 2, 2025

DENVER, Colo., 02 September, 2025 (www.247marketnews.com) – (NASDAQ:SSKN) are discussed in this article.
Strata Skin Sciences, Inc. (SSKN), a forward-thinking leader in medical technology focusing on dermatologic treatments, is navigating significant trading volatility. Opening at $3.53, shares have since fallen to around $2.728, marking a decline of approximately 14.62%. The previous closing price was $2.38, indicating a notable rise ahead of the current downturn. A robust trading volume of 44.83 million shares today reflects heightened investor engagement, potentially influenced by recent developments or prevailing market sentiments. Technical indicators suggest a bearish trend, prompting traders to watch key support levels at $2.38 and resistance near the opening price.

In a strategic move to strengthen its market presence, Dr. Dolev Rafaeli, President and CEO of STRATA, will deliver a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference from September 8 to 10, 2025. This presentation will be available on demand for registered investors from September 5 at 7:00 AM ET, highlighting STRATA’s dedication to fostering investor relations and sharing insights into its innovative dermatological solutions.

STRATA is recognized for its advanced products, including the XTRAC® excimer laser, VTRAC® lamp systems, and TheraClear®X Acne Therapy System, all designed to effectively treat various skin conditions like psoriasis, vitiligo, and acne. The Company is also enhancing treatment accessibility through its innovative Partnership Program, which offers a cost structure that eliminates traditional equipment purchases, facilitating the incorporation of its advanced therapies into medical practices.

As Strata Skin Sciences strives to explore new opportunities within the dermatology and aesthetics sectors, it invites stakeholders to engage with its strategic vision. Investors and healthcare professionals are encouraged to stay tuned for updates on the Company’s ambitious growth plans and commitment to transforming patient care in the dermatologic field.

Related news for (SSKN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.